Dr. Andrew Leber
Dr. Leber holds degrees from Penn State University and Virginia Tech in Bioengineering and Genetics, Bioinformatics and Computational Biology. His expertise spans immunology and drug development for autoimmune disease with a focus on immunometabolism. He has ample experience in assessing the therapeutic potential of lead immunoregulatory targets, preclinical and clinical development of drugs for Crohn’s disease and ulcerative colitis.
Bioengineering and Genetics, Bioinformatics and Computational Biology